Impact of Checkpoint Inhibitor Immunotherapy Primarily Pembrolizumab on Infection Risk in Patients with Advanced Lung Cancer: A Comparative Retrospective Cohort Study.
暂无分享,去创建一个
F. Fossella | D. Kontoyiannis | Patrick Chaftari | I. Raad | R. Hachem | A. Chaftari | G. Viola | Ying Jiang | J. Fares | A. Malek | V. Mulanovich | Melissa Khalil | Patrick S Chaftari